Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Primary Myelofibrosis × regorafenib × 1 year × Clear all

Sponsor

Conditions

Colorectal Neoplasms 29 Carcinoma, Hepatocellular 12 Glioblastoma 5 Colonic Neoplasms 5 Sarcoma, Ewing 3 Rectal Neoplasms 3 Osteosarcoma 3 Neoplasm Metastasis 3 Liver Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Leukemia, Myeloid, Acute 2 Gastrointestinal Stromal Tumors 2 Esophageal Squamous Cell Carcinoma 2 Esophageal Neoplasms 2 Chondrosarcoma 2 Astrocytoma 2 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Spinocerebellar Degenerations 1 Solid Malignant Tumors 1 Small Cell Lung Carcinoma 1 Recurrence 1 Patient Compliance 1 Pathologic Complete Response 1 Ovarian Neoplasms 1 Neoplasms 1 Myelodysplastic Syndromes 1

Interventions

ruxolitinib 19 Cyclophosphamide 11 Whole-Body Irradiation 9 Tacrolimus 8 fludarabine phosphate 7 fludarabine 7 Stem Cell Transplantation 7 Mycophenolic Acid 7 Specimen Handling 6 Peripheral Blood Stem Cell Transplantation 6 Azacitidine 5 Melphalan 4 Busulfan 4 Biopsy 4 fedratinib 3 Sirolimus 3 Methotrexate 3 Injections 3 venetoclax 2 selinexor 2 navitoclax 2 luspatercept 2 letermovir 2 itacitinib 2 bomedemstat 2 INCB057643 2 INCB039110 2 Hematopoietic Stem Cell Transplantation 2 Decitabine 2 Cyclosporine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡